Myocardial performance index combining systolic and diastolic myocardial performance in doxorubicin-treated patients and its correlation to conventional echo/Doppler indices

Pediatric Cardiology

Volumn 23, Issue 5, 2002, Pages 522-527

  Ocal B ^a,b   Oguz D ^a   Karademir, S ^a   Birgen, D ^a   Yuksek N ^a   Ertem, U ^a   Cabuk F ^a  

^a DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Anthracycline cardiotoxicity; Myocardial performance index

Indexed keywords

ANTHRACYCLINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOTOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DRUG INDUCED DISEASE; ECHOCARDIOGRAPHY; EVALUATION; FEMALE; HEART CONTRACTION; HEART EJECTION FRACTION; HEART INDEX; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE RELAXATION; HEART PERFORMANCE; HEART RATE; HUMAN; INFANT; INTERMETHOD COMPARISON; MALE; PATIENT MONITORING; PRESCHOOL CHILD; REPRODUCIBILITY; SINUS RHYTHM; SYSTOLE; TIME SERIES ANALYSIS; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHILD; DRUG EFFECT; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; PATHOPHYSIOLOGY;

ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOXORUBICIN; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MYOCARDIAL CONTRACTION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 85047686779     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00021001     Document Type: Article

References (25)

1. Billingham ME, Mason JW, Bristow MR, Daniels JR (1978) Anthracycline cardiotoxicity monitored by morphologic changes. Cancer Treatment Rep 62:865-872
2. Bloom KR, Bini RM, Williams CM, et al (1978) Echocardiography in adriamycin cardiotoxicity. Cancer 41:1265-1269
3. Bristow MR, Mason JW, Billingham ME, Daniels JR (1981) Dose - effects and structure - function relationship in doxorubicin cardiomyopathy. Am Heart J 102:709-718
4. Bu'Lock FA, Mott MG, Oakhill A, et al (1996) Early identification of anthracycline cardiomyopathy: possibilities and implications. Arch Dis Child 75:416-422
5. Bu'Lock FA, Mott MG, Oakhill A, et al (1999) Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: prospective study. Pediatr Cardiol 20:252-263
6. Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613-618
7. Druck MN, Gulenchyn KY, Evans WK, et al (1984) Radionuclide angiography and endomyocardial biopsy in the assessment of doxorubicin cardiotoxicity 53:1667-1674
8. Dujardin KS, Tei C, Yeo TC, et al (1998) Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic dilated cardiomyopathy. Am J Cardiol 82:1071-1076
9. Green MD, Speyer JL, Muggia EM (1984) Cardiotoxicity of anthracyclines. Eur J Cancer Clin Oncol 20:293-296
10. Isner JM, Ferrans VJ, Cohen SR, et al (1983) Clinical and morphological findings after anthracycline chemotherapy. Am J Cardiol 51:1167-1174
11. Lee BH, Goodenday LS, Muswick GJ, et al (1987) Alterations in left ventricular diastolic function with doxorubicin therapy. Am J Coll Cardiol 9:184-188
12. Lefrak E, Pitha J, Rosenheim S, Gottlieb JA (1973) A clinicopathological analysis of adriamycin cardiotoxicity. Cancer 32:302-314
13. Marchandise B, Schroeder E, Bosly A, et al (1989) Early detection of doxorubicin cardiotoxicity. Interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart J 118:92-98
14. Masuyama T, Lee JM, Tamai M, et al (1991) Pulmonary venous flow velocity pattern as assessed with transthoracic pulsed Doppler echocardiography in subjects without cardiac disease. Am J Cardiol 67:1396-1404
15. Praga C, Beretta G, Vigo PL, et al (1979) Adriamycin cardiotoxicity: a survey of 1273 patients. Cancer Treatment Rep 63:827-834
16. Sahn DJ, Demaria A, Kisslo J, Weyman A (1978) The committee on M-mode standardization of the American Society of Echocardiography recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072-1083
17. Schwartz RG, McKenzie WB, Alexander J, et al (1987) Congestive heart failure and left ventricular shortening fraction complicating doxorubicin therapy: seven year experience using serial radionuclide angiography. Am J Med 82:1109-1118
18. Stoddard MF, Seeger J, Liddell NE, et al (1992) Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll. Cardiol 20:62-69
19. Tei C (1995) New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 26:135-136
20. Tei C, Dujardin KS, Hodge DO, et al (1996) Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 9:838-847
21. Tei C, Dujardin KS, Hodge DO, et al (1996) Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 28:658-664
22. Tei C, Lieng HL, Hodge DO, et al (1995) New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol 26:357-366
23. Tei C, Nishimura RA, Seward JB, Tajik AJ (1997) Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardigr 10:169-178
24. Von Hoff DD, Layard MW, Basa P, et al (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:701-717
25. Von Hoff DD, Rozencweig M, Layard MW, et al (1977) Daunomycin-induced cardiomyopathy in children and adults. Am J Med 62:200-208